Public Employees Retirement Association of Colorado Has $1.70 Million Holdings in The Clorox Company (NYSE:CLX)

Public Employees Retirement Association of Colorado decreased its holdings in shares of The Clorox Company (NYSE:CLX) by 4.3% in the 2nd quarter, HoldingsChannel.com reports. The firm owned 12,452 shares of the company’s stock after selling 555 shares during the period. Public Employees Retirement Association of Colorado’s holdings in Clorox were worth $1,699,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. CIBC Private Wealth Group LLC lifted its position in shares of Clorox by 0.5% during the 4th quarter. CIBC Private Wealth Group LLC now owns 13,900 shares of the company’s stock worth $1,982,000 after buying an additional 66 shares during the last quarter. Lindbrook Capital LLC lifted its holdings in shares of Clorox by 6.2% in the first quarter. Lindbrook Capital LLC now owns 1,182 shares of the company’s stock worth $181,000 after acquiring an additional 69 shares during the last quarter. GHP Investment Advisors Inc. boosted its stake in shares of Clorox by 2.0% in the 2nd quarter. GHP Investment Advisors Inc. now owns 3,634 shares of the company’s stock valued at $496,000 after purchasing an additional 72 shares in the last quarter. Fiduciary Group LLC grew its holdings in shares of Clorox by 0.4% during the 2nd quarter. Fiduciary Group LLC now owns 19,050 shares of the company’s stock valued at $2,600,000 after purchasing an additional 72 shares during the last quarter. Finally, Mesirow Financial Investment Management Inc. increased its position in Clorox by 5.1% during the 2nd quarter. Mesirow Financial Investment Management Inc. now owns 1,702 shares of the company’s stock worth $233,000 after purchasing an additional 83 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Price Performance

Shares of NYSE CLX opened at $164.84 on Tuesday. The company has a market capitalization of $20.47 billion, a PE ratio of 85.41, a P/E/G ratio of 3.29 and a beta of 0.40. The company has a quick ratio of 0.63, a current ratio of 1.03 and a debt-to-equity ratio of 5.04. The Clorox Company has a twelve month low of $114.68 and a twelve month high of $169.09. The firm has a fifty day simple moving average of $149.75 and a 200 day simple moving average of $143.76.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Thursday, August 1st. The company reported $1.82 earnings per share for the quarter, topping the consensus estimate of $1.54 by $0.28. Clorox had a return on equity of 281.12% and a net margin of 3.95%. The firm had revenue of $1.90 billion during the quarter, compared to analyst estimates of $1.97 billion. On average, sell-side analysts forecast that The Clorox Company will post 6.63 EPS for the current year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be given a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a dividend yield of 2.96%. The ex-dividend date of this dividend is Wednesday, October 23rd. Clorox’s dividend payout ratio (DPR) is 252.85%.

Insider Activity

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the firm’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the completion of the sale, the executive vice president now directly owns 13,471 shares in the company, valued at $2,229,719.92. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 0.51% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on the stock. Barclays raised their target price on shares of Clorox from $122.00 to $130.00 and gave the company an “underweight” rating in a research report on Monday, August 5th. Argus upgraded Clorox to a “hold” rating in a research report on Tuesday, June 4th. DA Davidson reiterated a “neutral” rating and issued a $153.00 target price on shares of Clorox in a research report on Friday, September 6th. Citigroup boosted their price target on Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a report on Friday, September 6th. Finally, Wells Fargo & Company dropped their price objective on shares of Clorox from $135.00 to $130.00 and set an “underweight” rating for the company in a report on Wednesday, July 10th. Six investment analysts have rated the stock with a sell rating and twelve have given a hold rating to the company’s stock. According to data from MarketBeat, Clorox has an average rating of “Hold” and an average price target of $143.33.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.